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Abstract
HIV-infected women with excessive alcohol consumption are at risk for adverse health outcomes,
but little is known about their long-term drinking trajectories. This analysis included longitudinal
data, obtained from 1996–2006, from 2791 women with HIV from the Women’s Interagency HIV
Study. Among these women, the proportion in each of five distinct drinking trajectories was:
continued heavy drinking (3%), reduction from heavy to non-heavy drinking (4%), increase from
non-heavy to heavy drinking (8%), continued non-heavy drinking (36%), and continued non-
drinking (49%). Depressive symptoms, other substance use (crack/cocaine, marijuana, and
tobacco), co-infection with HCV, and heavy drinking prior to enrollment were associated with
trajectories involving future heavy drinking. In conclusion, many women with HIV change their
drinking patterns over time. Clinicians and those providing alcohol-related interventions might
target those with depression, current use of tobacco or illicit drugs, HCV infection, or a previous
history of drinking problems.
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BACKGROUND
Approximately half of US women with HIV infection report any alcohol consumption in the
past month, and at specific time points, approximately 12% – 22% exceed recommended
limits as established by the National Institute of Alcohol Abuse and Alcoholism (1–4).
Exceeding recommended consumption amounts, defined for women as drinking >7 drinks
per week or >3 drinks per occasion, is associated with poorer medication adherence,
increased risky sexual behavior, increased HIV viral load, and more rapid disease
progression (5–11). Most previous assessments of alcohol consumption and related
outcomes in HIV-infected women have focused on assessments at single time points.
However, because individuals often change their drinking patterns over time, assessments at
single time points likely do not accurately reflect their long-term drinking exposure, or their
risk of drinking in the future. Alcohol trajectory analysis can identify long-term drinking
patterns that may be associated with greater long-term consequences. Identification of
factors that are associated with the most severe long-term trajectories might identify current
drinkers at highest risk for continued long-term drinking, or those who are current non-
drinkers (or low-level drinkers) who are at greatest risk for increasing their drinking over
time, and therefore might be the target of concentrated preventive interventions.
Because alcohol consumption can have such significant health impacts in persons with HIV
infection, it is important to determine their drinking patterns over time and to infer whether
there are any differences in long-term drinking trajectories that are unique to women with
HIV. However, few if any assessments of long-term alcohol drinking trajectories have been
reported in HIV-infected women. Here, our objectives were to identify long-term drinking
trajectories during longitudinal follow-up in women with HIV infection, to identify baseline
characteristics of these women associated with the most serious long-term drinking
trajectories, and to compare long-term drinking trajectories in HIV-positive and HIV-
negative women.
METHODS
Data were obtained from 3766 women participating in the Women’s Interagency HIV Study
(WIHS), a prospective observational cohort study of HIV-positive and HIV-negative women
in the United States. The WIHS enrolled participants in 1994–1995 (n=2623) and again in
2000–2001 (N=1143). Participating sites are based in the Bronx and Brooklyn, New York
City; Washington DC, Los Angeles, the San Francisco Bay area, and Chicago. Institutional
Review Boards at each of the participating centers approved the WIHS study protocols, and
informed written consent was obtained from all participants. The study design has been
described previously (12, 13) and study information is available at https://
statepiaps.jhsph.edu/wihs/.
Data Collection
The baseline questionnaire, completed at study enrollment, included items to assess age,
race, educational attainment, marital status, and employment status. On the baseline
questionnaire, participants also indicated the quantity and frequency of use of the following
substances in the previous six months: tobacco, marijuana, cocaine, crack or freebase
cocaine, heroin, and methadone. Current drug use was defined as taking the drug at least
once a month. Participants also reported whether they had ever injected any drugs and
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whether they were currently injecting drugs. HIV serostatus was determined by ELISA
antibody testing and an approved confirmatory test and CD4 cell count was categorized as
<=200/mm3, 201–500/mm3, and >500/mm3. Information on the time since seroconversion
was not available. Depression was assessed using the 20-item CES-D scale; women were
classified as having clinically significant symptoms of depression if they had a CES-D score
of >=16 (14). Baseline blood specimens for the 1994/1995 recruits were tested in 2000 for
hepatitis C virus (HCV) infection, and the 2001/2002 recruits were tested in real time. Thus,
all women in active follow-up eventually learned their HCV status, although women
enrolled in 1994–95 were not given their HCV test results until later.
Alcohol assessment
WIHS has assessed alcohol quantity and frequency at enrollment and at each successive 6-
month visit. WIHS uses several strategies to maximize the validity of the alcohol assessment
information, including showing pictures of various drink types to participants and creating a
non-judgmental atmosphere. At the enrollment and each six-month follow-up visit, WIHS
participants were asked about the average number of days per week that they had a drink of
alcohol, defined as “one can, bottle or glass of beer, a glass of wine, a shot of liquor, a
mixed drink with that amount of liquor, or any other kind of alcoholic beverage.” Response
options were every day, 5–6 days a week, 3–4 days a week, 1–2 days a week, less than once
a week, and none. Next, they were asked about the usual number of drinks they consumed
per day, with open-ended responses elicited during 1996 – 2004 and categorized choices for
2005 onward (0, 1–2, 3–4, 5–6, or 7 or more drinks per day). Open-ended responses such as
“a pint of vodka” were converted to numbers of standard drinks. The number of drinks per
week was determined by multiplying the reported quantity by the reported frequency per
week. For these analyses, “heavy” drinking refers to consumption of >7 drinks per week, an
amount defined as exceeding recommended limits by the National Institute on Alcohol
Abuse and Alcoholism (4).
Past drinking behavior and treatment for drinking was assessed at study enrollment.
Specifically, women provided information about the highest amounts of alcohol they ever
regularly consumed in the past (categorized as past heavy, moderate, or non-drinking based
on National Institute of Alcohol Abuse and Alcoholism criteria), and on whether they ever
had received any type of treatment for alcohol problems (such as Alcoholics Anonymous,
inpatient or outpatient detoxification, medication prescriptions).
Statistical analyses
The WIHS data from 23 semiannual study visits (1996 – 2006) were included in these
analyses. The primary analyses included the women with HIV infection at enrollment,
although we also conducted a separate analysis among women without HIV and among the
entire sample combined (HIV-positive and HIV-negative). A semi-parametric group-based
logistic model was used to identify groups of homogenous drinking trajectories.
Specifically, the SAS macro PROC TRAJ was used to fit a linear mixture model that
quantified alcohol intake patterns over study follow up and classified them into groups of
homogenous drinking trajectories (15). This procedure sorts individual drinking curves into
clusters of similar shape by taking each person’s response of number of drinks/week over all
23 visits and estimates a single model. Models with four to nine categories were considered
and we chose the five-category model because it had the best fit to the data by the Baysean
Information Criterion (BIC). The results for these trajectory analyses were similar when we
excluded participants who had fewer than 3 follow-up visits, and thus we included data from
all enrolled women. We also ran PROC TRAJ separately in women with and without HIV
infection. The general trajectory patterns were similar.
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Multivariable logistic regression models were used to predict specific long-term drinking
trajectories using risk factors assessed at baseline. Two separate analyses were run, based on
women’s drinking status at study enrollment. First, among women with heavy drinking at
baseline, we compared those who continued to drink at heavy levels over time, to those who
decreased their drinking (or stopped completely). Second, among women with lower levels
of drinking (or no drinking) at baseline, we compared women who increased to heavy
drinking over time to those who remained non-drinkers or low-level drinkers. Stepwise
modeling was used to identify factors most strongly associated with specific drinking
trajectories. Potential variables considered included the enrollment values for participant
age, race, marital status, education, employment, study recruitment site, period of
enrollment, depressive symptoms, HCV status, other illicit and licit substance use, past
drinking amount, and past alcohol treatment. We examined the potential impact of HIV
serostatus and HIV disease stage on long-term drinking trajectories using data from the
entire sample (HIV-positive and HIV-negative). In this analysis, HIV disease stage at study
enrollment was included in the multivariable model as a 4- category variable (HIV-negative,
HIV+/CD4 <200 cells/mm3, HIV+/CD4 200–500 cells/mm3, and HIV+/CD4 >500 cells/
mm3), with other variables found to be significant in the HIV-stratified analysis also
included in the multivariable model.
RESULTS
Of the 3766 study participants, most (74%) were HIV-positive. Among the 2791 HIV-
positive women, mean age at enrollment was 35 years; 58% were African American, 24%
were Hispanic, and the remainder were primarily white (Table 1). Fewer than half were
married (37%), employed at enrollment (24%), or had greater than a high school education
(32%). About 1 in 5 (21%) had HCV antibodies. Other substance use at enrollment was
relatively common, and included tobacco (51%), marijuana (21%), crack/freebase (16%),
cocaine (12%), and heroin (10%). About a third of the women (35%) had a previous history
of regular heavy drinking (>7 drinks per week); and 20% reported a history of participation
in an alcohol treatment program. The HIV-negative women in WIHS had fairly similar
characteristics, although the HIV-negative women were more likely to be employed, to be
enrolled in the 2001/2002 cohort (vs. the 1994/1995 cohort), to have HCV antibodies, and to
use marijuana (see Table 1).
The analyses revealed five distinct long-term drinking trajectories (Figure 1). The proportion
of HIV-positive women in each group was: Group 1) continued heavy drinking (3%); Group
2) reduction from heavy to non-heavy drinking (4%); Group 3) increase from non-heavy to
heavy drinking (8%); Group 4) continued non-heavy drinking (36%), and Group 5)
continued non-drinking (49%). Thus, while many women changed their drinking patterns
over time, the majority of women with HIV infection either continued to drink but kept their
alcohol consumption below heavy levels (Group 4) or remained non-drinkers throughout
follow-up (Group 5).
Factors associate with distinct drinking trajectories in HIV-positive women
Among HIV-positive women with heavier drinking at baseline (Groups 1 and 2), those with
continued heavy drinking over time (Group 1) were significantly more likely to report
depressive symptoms (OR 1.6, 95% CI 1.0 – 2.8), crack/cocaine use at baseline (OR 3.6,
95% CI 2.1 – 6.0), or positive HCV antibody status (OR 1.8, 95% CI 1.1 – 3.0), compared to
women who reduced their heavy drinking over time (Group 2) (Table 2). The findings were
similar in HIV-uninfected women, other than depressive symptoms (Table 2).
Among HIV-positive women with non-heavy or no drinking at baseline (Groups 3, 4 and 5),
women were significantly more likely to increase to heavy drinking (Group 3) if they
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engaged in other illicit or licit substance use at baseline (cocaine, marijuana or tobacco), had
a history of heavy drinking prior to enrollment, or had ever participated in alcohol treatment
prior to enrollment (Table 3). Hepatitis C antibody status was not associated with drinking
trajectories in these women without heavy drinking at baseline. The results were similar in
women who were HIV-uninfected (Table 3).
In multivariable analyses that included the entire sample (HIV-positive and HIV-
uninfected), HIV infection status was not itself significantly associated with any of the
distinct trajectory patterns (data not shown).
DISCUSSION
Examination of long-term drinking trajectories in women with HIV infection is important, as
heavy alcohol consumption is associated with a wide range of behavioral and biologic health
outcomes including more rapid disease progression (5–11). Our investigation identified five
distinct long-term drinking trajectories in U.S. women with HIV infection. About a fifth of
these women had substantial changes in their drinking behavior over time, whereas the
remaining 80% continued either to not drink or to drink moderately. Drinking trajectory
patterns were similar among HIV-positive and HIV-uninfected women. Previous research,
including some from the same cohort,(3) has demonstrated that 12– 22% of HIV-infected
women meet criteria for heavy drinking at single time points (1–3, 7). However, many
women change their drinking behavior over time, and this longitudinal analysis suggest that
fewer than 5% will continue to drink at heavy levels over a longer period of time, whereas
another 10% will initiate (or re-initiate) drinking at a heavy level. Thus, clinicians caring for
adult women with HIV infection need to include repeated assessments of alcohol
consumption over time.
Most previous studies that examined drinking trajectories have presented results for trends
among adolescents as they emerge into adulthood (16–21), or reported studies that combined
men and women (22, 23), although some newer reports describe drinking trajectories in
adult U.S. women over age 50 (24, 25). It is difficult to compare trajectory patterns across
studies because the age groups, gender, or the number of trajectory categories were
different. However, the results from our study, showing changing drinking patterns over
time, are generally consistent with the findings from other cohorts of U.S. women.
In our study, women with depressive symptoms, who used other drugs such as crack/
cocaine, marijuana, and tobacco, or who had a past history of heavy drinking, were most
likely to be on trajectories associated with long-term heavy drinking. The few other studies
that examined specific risk factors associated with long-term trajectories also found that
previous drinking history, tobacco and drug use, and depression are associated with heavy
drinking over time (22, 23, 25). The finding that women who used tobacco and other drugs
were the most resistant to long-term moderation in drinking, suggests that intervention
strategies that address multiple substances concurrently may be needed (rather than targeting
single behaviors). The overlapping of several types of substance use mirror what we
previously found in different analyses of this cohort, in which both chronic problem
drinking and chronic crack use were associated with high viral load among women with
HIV infection (26), and polysubstance use was associated with decreased success in
smoking cessation in HIV-infected women (27).
This study has several strengths, including the repeated alcohol measures over time, use of
strategies to improve accuracy of alcohol consumption reporting, and an HIV-negative
control group. However, several study limitations should be noted. Although the WIHS
study used several strategies to enhance self-reporting of alcohol, alcohol consumption is
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subject to measurement error and most likely is under-reported. Thus, the actual proportion
of women with heavy drinking is likely to be somewhat higher. Some women were missing
data at some time points or may have dropped out of the cohort. We found similar results in
trajectories after excluding subjects with fewer than 3 outcome assessments, which suggests
that the data are robust to these issues.
We focused our analysis on whether baseline characteristics are associated with long-term
trajectories, although we recognize that several of the measures we assessed can change over
time and might influence future alcohol trajectory patterns. A focus on baseline
characteristics is most consistent with information a clinician might have when considering
the likelihood of future drinking trajectories (initial risk). Thus, the findings have relevance
for clinical screening and intervention programs. However, because many variables do
change over time, future analyses of this topic might consider an analytic approach that
incorporates behavior change over time in order to better understand the possible causal
associations between these factors and changes in drinking.
Health care providers caring for women with HIV infection should assess for current alcohol
consumption as well as identify women at increased risk for long-term drinking problems.
The findings from this study may help clinicians and public health providers to identify
women in need of more aggressive monitoring and possible intervention, regardless of their
current drinking behavior. For example, women with a previous history of heavy drinking
are at greater risk for long-term heavy drinking, even if they are not drinking heavily at the
current visit. At the same time, health care providers can provide positive reinforcement
towards the great majority of women who are not drinking at harmful levels, with more
emphasis on those factors associated with resiliency.
In summary, these findings suggest that over time, the majority of HIV-infected and at-risk
women will have long-term trajectories involving lower levels of drinking (or non-drinking).
However, approximately 1 in 10 adult women will either continue to drink at heavy levels or
increase their drinking to levels that exceed recommended guidelines. Past alcohol
consumption behavior, current use of tobacco and/or other drugs, and depressive symptoms
were the characteristics most strongly associated with long-term heavy drinking trajectories
in this analysis.
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Drinking trajectory patterns for 3768 women: Women’s Interagency HIV Study, 1994 –
2006. The five groups include (1) women who were persistent heavy drinkers (3%); (2)
women who cut back from heavy drinking to non-heavy drinking (4%); (3) women who
increased to heavy drinking over time (8%); (4) women who remained non-heavy drinkers
during the entire follow-up (36%); and (5) women who were non-drinkers (49%).
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<30 1039 (28) 652 (23) 387 (40) <.0001
30–40 1720 (46) 1343 (48) 377 (39)
>40 1007 (27) 796 (28) 211 (22)
Race
White 566 (15) 426 (15) 140 (14) 0.72
African American 2174 (58) 1617 (58) 557 (57)
Hispanic 901 24) 658 (24) 243 (25)
Other 125 (3.3) 90 (3.2) 35 (3.6)
Marital Status
Single 1315 (36) 915 (33) 400 (42) <.0001
Married 1381 (37) 1020 (37) 361 (38)
Sep/Div/Widowed 998 (27) 810 (30) 188 (20)
Employed 999 (27) 677 (24) 322 (33) <.0001
Education > High School 1204 (32) 887 (32) 317 (33) 0.60
Site
Bronx 772 (20 ) 547 (20) 225 (23) 0.06
Brooklyn 611 (16) 455 (16) 156 (16)
Washington DC 568 (15) 417 (15) 151 (16)
Los Angeles 762 (20) 572 (20) 190 (20)
San Francisco 580 (15) 427 (15) 153 (16)
Chicago 473 (12) 373 (13) 100 (10)
Year of Enrollment
1994/1995 2623 (70) 2054 (74) 569 (58) <.0001
2001/2002 1143 (30) 737 (26) 406 (42)
Clinical Characteristics
CD4 Group
<200/mm3 665 (25) 665 (25) --- ---
200–500/mm3 1171 (43) 1171 (43) ---
>500/mm3 868 (32) 868 (32) ---
HCV Antibody Positive 1152 (31) 197(21) 955 (35) <.0001
Depressive Symptoms (CESD>=16) 1953 (53) 1476 (54) 477 (50) 0.02
Drug Use at Baseline (at least monthly)
cocaine 460 (12) 324 (12) 136 (14) 0.06
heroin 395 (10) 284 (10) 111 (11) 0.29
























crack/freebase cocaine 626 (17) 442 (16) 184 (19) 0.03
(illicit) methadone 66 (1.8) 38 (1.4) 28 (2.9) 0.002
marijuana/hash 912 (24) 594 (21) 318 (33) <.0001
injected drug 307 (8) 225 (8.1) 82 (8.4) 0.74
tobacco 1986 (53) 1424 (51) 562 (58) 0.0004
Peak Drinking History (prior to baseline)
Non drinker 1985 (54) 1499 (55) 486 (51) 0.07
Moderate drinker 377 (10) 274 (10) 103 (11)
Heavy drinker 1329 (36) 957 (35) 372 (39)
Ever Had Alcohol Treatment (prior to baseline) 782 (21) 554 (20) 228 (24) 0.02
*
P-values for comparisons between HIV + and HIV − women.
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